BASF shares fell in trading on Tuesday after the German chemical conglomerate raised its full-year financial guidance, citing a stronger-than-anticipated second quarter.
The market reaction underscores a growing disconnect between corporate optimism and investor sentiment in the sector.
The company announced that its adjusted operating profit (Ebitda) for 2026 is now expected to range between €6.9 billion and €7.7 billion.
This upward revision reflects improved performance in the second quarter, which exceeded internal expectations.
Despite the positive fundamental update, BASF’s stock price declined, suggesting that traders are pricing in broader headwinds or skepticism regarding the sustainability of the recovery.
The sell-off aligns with a wider trend observed across equity markets, where relentless upward revisions to corporate earnings forecasts are increasingly viewed with caution.